Loratadine Reduces Cell Viability in Different Types of Human Cancer Cell Lines

dc.contributor.authorKeskin, Tuba
dc.contributor.authorSekerci, Guldeniz
dc.contributor.authorTekin, Suat
dc.date.accessioned2026-04-04T13:37:46Z
dc.date.available2026-04-04T13:37:46Z
dc.date.issued2025
dc.departmentİnönü Üniversitesi
dc.description.abstract[No abstract available]
dc.identifier.endpage66
dc.identifier.issn1748-1708
dc.identifier.issn1748-1716
dc.identifier.startpage66
dc.identifier.urihttps://hdl.handle.net/11616/110041
dc.identifier.volume241
dc.identifier.wosWOS:001430730700117
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofActa Physiologica
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250329
dc.subjectCancer
dc.subjectHistamine
dc.subjectLoratadine
dc.subjectA2780
dc.subjectCaco-2
dc.subjectLNCaP
dc.titleLoratadine Reduces Cell Viability in Different Types of Human Cancer Cell Lines
dc.typeConference Object

Dosyalar